Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2026-04-12 @ 9:03 PM
Study NCT ID:
NCT02283658
Status:
COMPLETED
Last Update Posted:
2020-10-23
First Post:
2014-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-14
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-21
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-03
First Submit QC Date:
None
Study First Post Date:
2014-11-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-15
Results First Submit QC Date:
None
Results First Post Date:
2020-03-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-28
Last Update Post Date:
2020-10-23
Last Update Post Date Type:
ACTUAL